OptimizeRx Reports Third Quarter 2024 Financial Results
Provided By GlobeNewswire
Last update: Nov 13, 2024
- Q3 revenue of $21.3 million, increasing 30% year-over-year
- Q3 gross profit increased 37% year-over-year to $13.4 million with a gross margin of 63%
- Won 5 DAAP deals during Q3
